Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000652162 | SCV000774030 | benign | Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome; Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency | 2024-01-25 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV001263284 | SCV001441322 | uncertain significance | Recurrent infections | 2019-05-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003437381 | SCV004148311 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | STAT1: PP2, BP4, BS2 |
Mayo Clinic Laboratories, |
RCV003437381 | SCV004225971 | uncertain significance | not provided | 2022-08-12 | criteria provided, single submitter | clinical testing | BP4, PP2 |
Prevention |
RCV004544899 | SCV004769515 | likely benign | STAT1-related disorder | 2024-02-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |